Sandra Canosa, MSc, CCRP

Mrs. Canosa’s scientific career encompasses more than two decades of biomedical research at Yale University and the Howard Hughes Medical Institute. She did her undergraduate studies in biology at the University of California, Santa Cruz before completing her Master’s in applied genomics at the University of Connecticut. As a research associate in the pathology labs of Yale School of Medicine, Mrs. Canosa has worked extensively with microarray expression profiling, genotyping, and DNA sequencing. In 2011, she joined the institution’s molecular diagnostics laboratory where she developed translational next generation sequencing assays and bioinformatics workflows for the Tumor Profiling Lab of the Yale Cancer Center. This work led to the laboratory's selection as a sequencing center for the NCI-MATCH clinical trial, and the creation of The Yale Clinical Molecular Pathology Laboratory, which supports clinical trials by offering custom assays for integral biomarkers, a function critical to Precision Medicine initiatives. Following the conclusion of that clinical trial, Mrs. Canosa was recruited to manage Yale Cancer Center's Clinical Research Support Laboratories in New Haven, where specimens for over 400 oncology clinical trials are processed.